HOPO Therapeutics reposted this
The nation must stay ready for public health emergencies, including radiological incidents and toxic heavy metal exposures. That’s why we’re partnering with HOPO Therapeutics to advance development of HOPO-101, an easy-to-administer oral decorporation agent intended to treat internal contamination from radionuclides (radioactive forms of elements) and toxic heavy metals. Learn more about this partnership and other opportunities: https://ow.ly/WIhP50TSuKy
Maintaining our CBRN readiness is a vital part of our National Security. We must be prepared for EID threats but we cannot loose or stop advancing our preparedness for CBRN. Thanks to BARDA for continuing this work.